vs
LEE ENTERPRISES, Inc(LEE)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是LEE ENTERPRISES, Inc的1.5倍($197.9M vs $130.1M),REPLIGEN CORP净利率更高(6.7% vs -4.3%,领先11.0%),REPLIGEN CORP同比增速更快(13.6% vs -10.0%),REPLIGEN CORP自由现金流更多($17.6M vs $3.7M),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs -5.8%)
李企业是一家上市美国传媒企业,在全美25个州运营着72份日报,同时还经营超过350份周报、分类广告刊物及各类专业刊物。公司由阿尔弗雷德·威尔逊·李于1890年创立,总部坐落于爱荷华州达文波特。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
LEE vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.5倍
$130.1M
营收增速更快
RGEN
高出23.7%
-10.0%
净利率更高
RGEN
高出11.0%
-4.3%
自由现金流更多
RGEN
多$13.8M
$3.7M
两年增速更快
RGEN
近两年复合增速
-5.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $130.1M | $197.9M |
| 净利润 | $-5.6M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 4.0% | 9.0% |
| 净利率 | -4.3% | 6.7% |
| 营收同比 | -10.0% | 13.6% |
| 净利润同比 | 66.5% | 143.9% |
| 每股收益(稀释后) | $-0.92 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LEE
RGEN
| Q4 25 | $130.1M | $197.9M | ||
| Q3 25 | $139.1M | $188.8M | ||
| Q2 25 | $141.3M | $182.4M | ||
| Q1 25 | $137.4M | $169.2M | ||
| Q4 24 | $144.6M | $174.1M | ||
| Q3 24 | $158.6M | $154.9M | ||
| Q2 24 | $150.6M | $154.1M | ||
| Q1 24 | $146.6M | $151.3M |
净利润
LEE
RGEN
| Q4 25 | $-5.6M | $13.3M | ||
| Q3 25 | $-6.4M | $14.9M | ||
| Q2 25 | $-1.9M | $14.9M | ||
| Q1 25 | $-12.5M | $5.8M | ||
| Q4 24 | $-16.7M | $-30.3M | ||
| Q3 24 | $-10.1M | $-654.0K | ||
| Q2 24 | $-4.3M | $3.3M | ||
| Q1 24 | $-12.2M | $2.1M |
毛利率
LEE
RGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率
LEE
RGEN
| Q4 25 | 4.0% | 9.0% | ||
| Q3 25 | -1.0% | 8.9% | ||
| Q2 25 | 3.3% | 7.6% | ||
| Q1 25 | -3.3% | 3.9% | ||
| Q4 24 | -2.3% | -17.7% | ||
| Q3 24 | -2.3% | -5.1% | ||
| Q2 24 | 3.3% | 1.0% | ||
| Q1 24 | -3.1% | 1.3% |
净利率
LEE
RGEN
| Q4 25 | -4.3% | 6.7% | ||
| Q3 25 | -4.6% | 7.9% | ||
| Q2 25 | -1.4% | 8.2% | ||
| Q1 25 | -9.1% | 3.4% | ||
| Q4 24 | -11.6% | -17.4% | ||
| Q3 24 | -6.4% | -0.4% | ||
| Q2 24 | -2.8% | 2.2% | ||
| Q1 24 | -8.3% | 1.4% |
每股收益(稀释后)
LEE
RGEN
| Q4 25 | $-0.92 | $0.24 | ||
| Q3 25 | $-1.02 | $0.26 | ||
| Q2 25 | $-0.31 | $0.26 | ||
| Q1 25 | $-2.07 | $0.10 | ||
| Q4 24 | $-2.80 | $-0.55 | ||
| Q3 24 | $-1.68 | $-0.01 | ||
| Q2 24 | $-0.73 | $0.06 | ||
| Q1 24 | $-2.06 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $12.6M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $-48.7M | $2.1B |
| 总资产 | $592.6M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
LEE
RGEN
| Q4 25 | $12.6M | $767.6M | ||
| Q3 25 | $10.0M | $748.7M | ||
| Q2 25 | $14.1M | $708.9M | ||
| Q1 25 | $4.7M | $697.2M | ||
| Q4 24 | $6.1M | $757.4M | ||
| Q3 24 | $9.6M | $784.0M | ||
| Q2 24 | $13.4M | $809.1M | ||
| Q1 24 | $16.1M | $780.6M |
总债务
LEE
RGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
LEE
RGEN
| Q4 25 | $-48.7M | $2.1B | ||
| Q3 25 | $-43.3M | $2.1B | ||
| Q2 25 | $-40.5M | $2.1B | ||
| Q1 25 | $-38.9M | $2.0B | ||
| Q4 24 | $-26.7M | $2.0B | ||
| Q3 24 | $-9.9M | $2.0B | ||
| Q2 24 | $4.0M | $2.0B | ||
| Q1 24 | $7.9M | $2.0B |
总资产
LEE
RGEN
| Q4 25 | $592.6M | $2.9B | ||
| Q3 25 | $601.7M | $2.9B | ||
| Q2 25 | $622.7M | $2.9B | ||
| Q1 25 | $623.9M | $2.9B | ||
| Q4 24 | $633.0M | $2.8B | ||
| Q3 24 | $649.2M | $2.8B | ||
| Q2 24 | $677.5M | $2.9B | ||
| Q1 24 | $684.8M | $2.8B |
负债/权益比
LEE
RGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $4.5M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $3.7M | $17.6M |
| 自由现金流率自由现金流/营收 | 2.9% | 8.9% |
| 资本支出强度资本支出/营收 | 0.6% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $1.5M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
LEE
RGEN
| Q4 25 | $4.5M | $25.7M | ||
| Q3 25 | $-6.3M | $48.1M | ||
| Q2 25 | $8.9M | $28.6M | ||
| Q1 25 | $-790.0K | $15.0M | ||
| Q4 24 | $-7.3M | $39.2M | ||
| Q3 24 | $-261.0K | $49.3M | ||
| Q2 24 | $-1.9M | $42.2M | ||
| Q1 24 | $3.2M | $44.7M |
自由现金流
LEE
RGEN
| Q4 25 | $3.7M | $17.6M | ||
| Q3 25 | $-8.3M | $43.4M | ||
| Q2 25 | $8.3M | $21.5M | ||
| Q1 25 | $-2.2M | $11.4M | ||
| Q4 24 | $-8.9M | $33.6M | ||
| Q3 24 | $-2.9M | $42.3M | ||
| Q2 24 | $-5.5M | $37.4M | ||
| Q1 24 | $1.3M | $36.4M |
自由现金流率
LEE
RGEN
| Q4 25 | 2.9% | 8.9% | ||
| Q3 25 | -6.0% | 23.0% | ||
| Q2 25 | 5.9% | 11.8% | ||
| Q1 25 | -1.6% | 6.8% | ||
| Q4 24 | -6.1% | 19.3% | ||
| Q3 24 | -1.8% | 27.3% | ||
| Q2 24 | -3.6% | 24.3% | ||
| Q1 24 | 0.9% | 24.0% |
资本支出强度
LEE
RGEN
| Q4 25 | 0.6% | 4.1% | ||
| Q3 25 | 1.4% | 2.5% | ||
| Q2 25 | 0.4% | 3.9% | ||
| Q1 25 | 1.0% | 2.1% | ||
| Q4 24 | 1.1% | 3.2% | ||
| Q3 24 | 1.7% | 4.5% | ||
| Q2 24 | 2.4% | 3.1% | ||
| Q1 24 | 1.3% | 5.5% |
现金转化率
LEE
RGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LEE
| Advertising And Marketing Services | $60.0M | 46% |
| Subscription And Circulation | $57.7M | 44% |
| Other | $12.4M | 10% |
RGEN
暂无分部数据